An observational study in Acute Coronary Syndrome, sponsored by Sohag University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-06.
Sponsored by Sohag University · Observational
This study aims to determine the relation between high homocysteine levels and increased incidence of acute coronary syndrome in young patients
Cross sectional study to:
assess homocysteine level in young adult patients presenting with acute coronary syndrome
1,461 studies on the registry are indexed under Acute Coronary Syndrome; 267 are open to participants now.
This study's enrollment of 100 is below the median of 500 across 561 observational studies indexed under Acute Coronary Syndrome.
Browse Acute Coronary Syndrome studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients presented with acute coronary syndrome admitted to coronary care unit of Sohag University hospital according to inclusion and exclusion criteria
The patients who presented in the hospital with chest pain consistent with acute coronary syndrome with any of the following features:
Electrocardiogram (ECG) changes:
Troponin T elevation (Norma value \< 0.06)
2- Age: -Between 18- 40 years (Group A) - Age > 40 years (Group B)
Exclusion Criteria:
diagnostic test
Also known as: HCY
Coronary care unit admission with acute coronary syndrome
Acute coronary syndrome hospitalization and cardiovascular deathes and estimated hazard ratios (HR) by use of multivariable Cox regression models
Time frame: From date of randomization up to 1 month
Plan to share: Undecided
This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University